PARP1 and cystic fibrosis: We observed higher PARP-1 activity in HBEs derived from patients homozygous for ΔF508 CFTR than in HBEs from non-CF donors, and similarly higher activity in the CFBE41o− cell line compared to the non-CF line 16HBE14o−.